These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Determination of antibodies to erythrogenic toxin in the passive hemagglutination reaction]. Kazdobina IS Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):43-7. PubMed ID: 5616806 [No Abstract] [Full Text] [Related]
7. [Study of the immunological and epidemiological activity of purified sorbed scarlet fever toxin]. MITEL'MAN SL Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():70-5. PubMed ID: 13771373 [No Abstract] [Full Text] [Related]
8. [Evaluation of a new polyvalent rapid test for detection of anti-streptococcal antibodies (experience in 50 cases of scarlet fever)]. Ulivelli A; Silenzi M Minerva Pediatr; 1974 Sep; 26(27):1325-39. PubMed ID: 4376211 [No Abstract] [Full Text] [Related]
10. [Erythrogenic toxin. II. The problem of antigenic heterogeneity of scarlet fever toxin. Neutralization tests]. SCHUH V; JELINEK J Cesk Epidemiol Mikrobiol Imunol; 1960 Sep; 9():476-84. PubMed ID: 13748788 [No Abstract] [Full Text] [Related]
11. [APPLICATION OF THE PASSIVE HEMAGGLUTINATION METHOD FOR DETERMINATION OF ANTIBODIES TO THE STREPTOCOCCUS ALLERGEN IN THE SERUM OF PATIENTS WITH RHEUMATISM]. SMIRNOVA MN Zh Mikrobiol Epidemiol Immunobiol; 1964 Sep; 41():50-5. PubMed ID: 14279477 [No Abstract] [Full Text] [Related]
12. [Use of hemagglutination reaction in the titration of anti-scarlet fever sera]. KUSHKO IV Zh Mikrobiol Epidemiol Immunobiol; 1960 May; 31():36-9. PubMed ID: 14412942 [No Abstract] [Full Text] [Related]
13. [Comparative characteristics of the immunologic structure of children's collectives as regards scarlatina in different climatic zones]. Silich VA; Dodonov VN; Fiks LI; Severov AM; Strel'tsova NA Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):62-6. PubMed ID: 125514 [TBL] [Abstract][Full Text] [Related]
14. [The importance of C-reactive protein (CRP) in scarlet fever diagnosis (author's transl)]. Ulivelli A; Di Maria M Ann Sclavo; 1980; 22(3):444-9. PubMed ID: 7247496 [TBL] [Abstract][Full Text] [Related]
15. Reactions to intradermal administration of scarlet fever streptococcus toxin in rheumatic cardiac children. DOWD HL; WASSON VP; BROWN EE Arch Pediatr (N Y); 1945 Dec; 62():549-53. PubMed ID: 21010702 [No Abstract] [Full Text] [Related]
16. The anti-MAP and anti-group A carbohydrate antibodies response in streptococcal human infections. Mihalcu F; Stefãnescu M Dev Biol Stand; 1975; 28():435-8. PubMed ID: 1126583 [TBL] [Abstract][Full Text] [Related]
17. [Occurrence of normal antibodies in humans for somatic (group) antigens of Klebsiella]. Kaluzewski S Med Dosw Mikrobiol; 1969; 21(3):271-84. PubMed ID: 5355651 [No Abstract] [Full Text] [Related]
18. Anti-streptopolysaccharide antibody in children with rheumatic fever and scarlet fever. Watanabe N; Mikuni K; Nakamura Y Jpn Circ J; 1987 Dec; 51(12):1350-2. PubMed ID: 3327951 [TBL] [Abstract][Full Text] [Related]
19. THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE. SCHUH V Folia Microbiol (Praha); 1965 May; 10():156-62. PubMed ID: 14344773 [No Abstract] [Full Text] [Related]
20. [Study of scarlatina toxin and streptococcal proteinase preparations by intradermal administration to rabbits]. Akimova VV; Gnezditskaia EV; Burshteĭn VA Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov; 47(11):30-4. PubMed ID: 5505307 [No Abstract] [Full Text] [Related] [Next] [New Search]